Spectral flow cytometry system is cleared for clinical use in China
Cytek Biosciences has received approval from the China National Medical Products Administration for its Northern Lights flow cytometer with 24+ color capability for clinical diagnostic use.
Flow cytometry instrumentation developer Cytek Biosciences (Fremont, CA) has received approval from the China National Medical Products Administration (NMPA) for its Northern Lights flow cytometer with 24+ color capability for clinical diagnostic use in hospitals, laboratories, and clinics across China. The achievement follows the company's DxP Athena systems being cleared by the NMPA.
The Northern Lights flow cytometer is upgradeable and available in configurations from one laser (nine colors) to three lasers (24+ colors), and offers high sensitivity and reagent flexibility. With several configurations available, the flow cytometer targets scientists who have budgeted for a one- to three-laser system, but desire the ability to run panels of higher complexity. Until now, such panels would only be achievable using a conventional flow cytometer's most expensive configuration.
The company anticipates NMPA approval for its complete system application solution soon.
For more information, please visit cytekbio.com.